CHSCO
CHS INC
$26.21
+0.23%
$321.6M
No data for this timeframe.
Vol
Market Cap$321.6M
Cap SizeSmall Cap
SEC Reports3
Exchange Nasdaq·Sector Wholesale-Farm Product Raw Materials·Inc. MN·CIK 0000823277·Prev Close $26.15
Recent Activity
Apr 21, 2026
SEC
CHS Inc. reported a net loss of $147.1 million on $8.4 billion in revenue for Q2 fiscal year 2026, compared to a net los
8-K — Impact 7/10
Apr 7, 2026
SEC
CHS Inc. declared regular quarterly dividends on its various series of preferred stock, including $0.50 per share on its
8-K — Impact 3/10
Apr 3, 2026
SEC
Daniel Schurr resigned from CHS Inc.'s Board of Directors effective March 30, 2026, after serving since 2006 and as Chai
8-K — Impact 3/10
Latest Reports
BEARISH
8-K
7/10
CHS Inc. reported a net loss of $147.1 million on $8.4 billion in revenue for Q2 fiscal year 2026, compared to a net los
Apr 21, 2026
NEUTRAL
8-K
3/10
CHS Inc. declared regular quarterly dividends on its various series of preferred stock, including $0.50 per share on its
Apr 7, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
3 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 0 mixed, 2 neutral. Avg impact: 4.3/10.
BEARISH
8-K
7/10
CHS Inc. reported a net loss of $147.1 million on $8.4 billion in revenue for Q2 fiscal year 2026, c
Apr 21, 2026
NEUTRAL
8-K
3/10
CHS Inc. declared regular quarterly dividends on its various series of preferred stock, including $0
Apr 7, 2026
NEUTRAL
8-K
3/10
Daniel Schurr resigned from CHS Inc.'s Board of Directors effective March 30, 2026, after serving si
Apr 3, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.